HIMENSION CAPITAL (SINGAPORE) PTE. LTD.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1817652
SINGAPORE, U0
Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,459,480
+$1,102,253 QoQ
Shares Held
18,136
+37.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#233
of 785 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HIMENSION CAPITAL (SINGAPORE) PTE. LTD. holds $26,277,467 across 21 Biotechnology names. ALNY ranks #2 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTLA |
Intellia Therapeutics, Inc.
|
326,893 | $5,531,029 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
18,136 | $5,459,480 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
83,897 | $4,575,742 | |
| 4 | MRNA |
Moderna, Inc.
|
25,218 | $1,766,016 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
36,419 | $1,249,900 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
5,653 | $1,058,693 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
50,111 | $937,576 | |
| 8 | ABVX |
Abivax S.A.
|
4,591 | $611,796 |
All Filings in ALNY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,459,480 | 18,136 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,357,227 | 13,169 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,050,065 | 10,185 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,602,864 | 10,094 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,397,649 | 13,486 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,131,846 | 15,302 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,065,718 | 4,529 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||